## Market Update: OMXS30 Index and European Markets
At around 12:30, the Swedish large-cap index OMXS30 was down by 0.3% at the level of 2,581. Stocks worth approximately 3.9 billion SEK had been traded on the Stockholm Stock Exchange as a whole. In Europe, the German DAX index was up by 0.2%, while the French CAC40 was down by 0.3%.
### Top Gainers and Losers in the OMXS30
#### Top Gainers:
– ABB and Astra Zeneca both strengthened by around 1% each.
– Astra Zeneca, along with Daiichi Sankyo, received approval in China for the drug Enhertu in the treatment of a form of non-small cell lung cancer.
– Ericsson climbed by 0.7% after winning a multi-billion dollar contract from Indian company Bharti Airtel.
#### Top Losers:
– SBB and Evolution were both down by approximately 3%.
– Evolution was affected by reports of potential tax increases for the British betting sector, leading to a downturn in iGaming stocks.
– Betsson also saw a decline of nearly 4%.
– Tele2 fell by 2.9% as its stock traded ex-dividend.
### Other Market Movements
– Munters dropped by over 7% after Carnegie downgraded its recommendation on the stock to sell from hold.
– Note released its third-quarter report, surpassing expectations with an adjusted operating margin of 8.3%.
– Kambi signed a partnership agreement with Hard Rock Digital, boosting its stock by 2.6%.
– Saniona received a milestone payment from Boehringer Ingelheim, lifting its stock by 1.2%.
– Humana saw a 3.5% increase after Kepler Cheuvreux upgraded its recommendation to buy with a higher price target.
– Engcon gained almost 6% as Handelsbanken Capital Markets initiated coverage with an outperform rating.
– Surgical Science received a buy recommendation from Dagens industri, indicating a potential opportunity for investors.
By providing this comprehensive market update, investors can stay informed about the latest movements in key stocks and indices, enabling them to make more informed decisions about their investment portfolios. Understanding these market dynamics is crucial for anyone looking to secure their financial future and navigate the complexities of the stock market effectively.